Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00002860 · ClinicalTrials.gov registry record · Phase 2

SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma

A Phase 2 study of Melanoma (Skin), sponsored by SWOG Cancer Research Network.

Completed
Registry status
Phase 2
Development phase
77
Enrollment target
20
Study locations

NCT00002860 is a Phase 2 study of Melanoma (Skin) that has completed, run by SWOG Cancer Research Network. The registered enrollment target is 77 participants, below the 134-participant average among 30 other Melanoma (Skin) trials with a reported enrollment target (43% lower). The trial reports 20 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00002860, a Phase 2 study of Melanoma (Skin), has completed, sponsored by SWOG Cancer Research Network.

COMPLETED
Registry status
Phase 2
Development phase
77 participants
Enrollment target
20
Study locations

Study Summary

RATIONALE: Surgery may be effective therapy in treating patients with metastatic melanoma. PURPOSE: This phase II trial is studying how well surgery works in treating patients with metastatic melanoma.

Conditions Studied

Melanoma (Skin)

Interventions

  • PROCEDURE Surgery

Study Locations (20)

Kansas

  • Cancer Center of Kansas - Chanute - Chanute
  • Cancer Center of Kansas - Dodge City - Dodge City
  • Cancer Center of Kansas, P.A. - El Dorado - El Dorado
  • Veterans Affairs Medical Center - Kansas City - Kansas City
  • Cancer Center of Kansas - Kingman - Kingman
  • Southwest Medical Center - Liberal

Arizona

  • Banner Good Samaritan Medical Center - Phoenix
  • CCOP - Western Regional, Arizona - Phoenix
  • Banner Thunderbird Medical Center - Phoenix
  • Arizona Cancer Center at University of Arizona Health Sciences Center - Tucson

Iowa

  • Siouxland Regional Cancer Center - Sioux City
  • Siouxland Hematology-Oncology Associates - Sioux City
  • Mercy Medical Center - Sioux City - Sioux City
  • St. Luke's Regional Medical Center - Sioux City

Colorado

  • North Colorado Medical Center - Greeley
  • McKee Medical Center - Loveland

Illinois

  • Saint Anthony's Hospital at Saint Anthony's Health Center - Alton
  • Good Samaritan Regional Health Center - Mount Vernon

Alaska

  • Alaska Regional Hospital Cancer Center - Anchorage

Florida

  • Baptist Cancer Institute - Jacksonville - Jacksonville

Trial Details

FieldValue
Enrollment Target 77 participants
Start Date 1996-11
Est. Completion 2010-12
Phase Phase 2

Sponsor

SWOG Cancer Research Network

270 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00002860

The ClinicalTrials.gov registry entry for NCT00002860 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 134-participant average among 30 other Melanoma (Skin) trials with a reported enrollment target (43% lower). The listed sponsor is SWOG Cancer Research Network, which has 270 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Melanoma (Skin) appearing as the primary indexed condition, and to 1 intervention - of which Surgery is the first listed.

NCT00002860 reports 20 study locations spanning 7 distinct geographic areas - top geographies include Kansas, Arizona, Iowa.

Frequently Asked Questions

What is clinical trial NCT00002860 about?

NCT00002860 is a clinical study titled "SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma". RATIONALE: Surgery may be effective therapy in treating patients with metastatic melanoma. PURPOSE: This phase II trial is studying how well surgery works in treating patients with metastatic melanoma.

What is the current status of trial NCT00002860?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 77 participants. The study started on 1996-11. Estimated completion is 2010-12.

What conditions does trial NCT00002860 study?

This clinical trial studies the following conditions: Melanoma (Skin).

What interventions are being tested in trial NCT00002860?

The interventions under investigation include: Surgery (PROCEDURE).

Who is sponsoring clinical trial NCT00002860?

This trial is sponsored by SWOG Cancer Research Network, which has 270 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00002860 being conducted?

This trial has 20 study locations across Alaska, Arizona, Colorado, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Melanoma (Skin)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Melanoma (Skin)

All registered trials for this condition

Alaska

All trials with a study site in Alaska

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.